Michael J. Massare

2.8k citations

19 papers · 1.3k indexed · h-index 14

Impact in

Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- Viral gastroenteritis research and epidemiology
- COVID-19 Clinical Research Studies
Animal Science and Zoology top 5%
- Animal Virus Infections Studies

Papers in

Infectious Diseases 11
- SARS-CoV-2 and COVID-19 Research 5
- Viral gastroenteritis research and epidemiology 4
Epidemiology 15
- Respiratory viral infections research 11
- Influenza Virus Research Studies 6
- Virology and Viral Diseases 3

Co-authors: Gale Smith Gregory M. Glenn David C. Flyer Bin Zhou Matthew B. Frieman Nita Patel Ye V. Liu Jing-Hui Tian
Journals: Vaccine (8 papers)Vaccines (2 papers)Journal of Virology (2 papers)PLoS ONE (2 papers)Clinical Infectious Diseases (1 paper)
Partner nations: United States

In The Last Decade

Michael J. Massare

19 papers receiving 1.2k citations

Peers

Countries citing papers authored by Michael J. Massare

Since Specialization

Citations

This map shows the geographic impact of Michael J. Massare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Massare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Massare more than expected).

Fields of papers citing papers by Michael J. Massare

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Massare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Massare. The network helps show where Michael J. Massare may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael J. Massare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael J. Massare Line = papers co-authored together Michael J. Massare links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Severe Acute Respiratory Syndrome Coronavirus 2 Receptor (Human Angiotensin-Converting Enzyme 2) Binding Inhibition Assay: A Rapid, High-Throughput Assay Useful for Vaccine Immunogenicity Evaluation Microorganisms ·Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, Edmond Massuda, Urvashi Patel, Andrew Klindworth, Michael J. Massare, Rongman Cai, Louis Fries, Greg Glenn, Raj Kalkeri	2023	6
2	Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine Clinical Infectious Diseases ·Vivek Shinde, Rongman Cai, Joyce S. Plested, Iksung Cho, Jamie Fiske, Xuan Da Pham, Mingzhu Zhu, Shane Cloney-Clark, Nan Wang, Haixia Zhou, Bin Zhou, Nita Patel, Michael J. Massare, Amy Fix, Michelle Spindler, D. Nigel Thomas, Gale Smith, Louis Fries, Gregory M. Glenn	2020	20
3	Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate Science ·Sandhya Bangaru, Gabriel Ozorowski, Hannah L. Turner, Aleksandar Antanasijevic, Deli Huang, Xiaoning Wang, Jonathan L. Torres, Jolene K. Diedrich, Jing-Hui Tian, Alyse D. Portnoff, Nita Patel, Michael J. Massare, John R. Yates, David Nemazee, James C. Paulson, Greg Glenn, Gale Smith, Andrew B. Ward	2020	228
4	Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance Vaccine ·Pamela J. Bruce-Staskal, Robert M. Woods, Oleg Borisov, Michael J. Massare, Timothy Hahn	2020	4
5	NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge Vaccine ·Mimi Guebre‐Xabier, Nita Patel, Jing-Hui Tian, Bin Zhou, Sonia Maciejewski, Kristal Lam, Alyse D. Portnoff, Michael J. Massare, Matthew B. Frieman, Pedro A. Piedra, Larry Ellingsworth, Gregory M. Glenn, Gale Smith	2020	149
6	Influenza Hemagglutinin Nanoparticle Vaccine Elicits Broadly Neutralizing Antibodies against Structurally Distinct Domains of H3N2 HA Vaccines ·Alyse D. Portnoff, Nita Patel, Michael J. Massare, Haixia Zhou, Jing-Hui Tian, Bin Zhou, Vivek Shinde, Gregory M. Glenn, Gale Smith	2020	26
7	Flexible RSV Prefusogenic Fusion Glycoprotein Exposes Multiple Neutralizing Epitopes that May Collectively Contribute to Protective Immunity Vaccines ·Nita Patel, Jing-Hui Tian, Rhonda Flores, Kelsey Jacobson, Michelle Walker, Alyse D. Portnoff, Mimi Gueber-Xabier, Michael J. Massare, Greg Glenn, Larry Ellingsworth, Gale Smith	2020	20
8	Maternal immunization with RSV fusion glycoprotein vaccine and substantial protection of neonatal baboons against respiratory syncytial virus pulmonary challenge Vaccine ·Charles Welliver, James F. Papin, Alisha Preno, Vadim A. Ivanov, Jing-Hui Tian, Hanxin Lu, Mimi Guebre‐Xabier, David C. Flyer, Michael J. Massare, Greg Glenn, Larry Ellingsworth, Gale Smith	2019	9
9	Structure basis of neutralization by a novel site II/IV antibody against respiratory syncytial virus fusion protein PLoS ONE ·Qingqing Xie, Zhao Wang, Fengyun Ni, Xiaorui Chen, Jianpeng Ma, Nita Patel, Hanxin Lu, Ye Liu, Jing-Hui Tian, David C. Flyer, Michael J. Massare, Larry Ellingsworth, Gregory M. Glenn, Gale Smith, Qinghua Wang	2019	9
10	Novel hemagglutinin nanoparticle influenza vaccine with Matrix-M™ adjuvant induces hemagglutination inhibition, neutralizing, and protective responses in ferrets against homologous and drifted A(H3N2) subtypes Vaccine ·Gale Smith, Ye Liu, David C. Flyer, Michael J. Massare, Bin Zhou, Nita Patel, Larry Ellingsworth, Maggie Lewis, James F. Cummings, Greg Glenn	2017	35
11	Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets Virology ·Gale Smith, Xiangjie Sun, Yaohui Bai, Ye V. Liu, Michael J. Massare, Melissa B. Pearce, Jessica A. Belser, Taronna R. Maines, Hannah M. Creager, Gregory M. Glenn, David C. Flyer, Peter Pushko, Min Z. Levine, Terrence M. Tumpey	2017	36
12	Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice Vaccine ·Karin Lövgren Bengtsson, Haifeng Song, Linda Stertman, Ye Liu, David C. Flyer, Michael J. Massare, Ren-Huan Xu, Bin Zhou, Hanxin Lu, Steve Kwilas, Timothy Hahn, Eloi Kpamegan, Jay W. Hooper, Ricardo Carrion, Gregory M. Glenn, Gale Smith	2016	94
13	Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets Vaccine ·Ye V. Liu, Michael J. Massare, Melissa B. Pearce, Xiangjie Sun, Jessica A. Belser, Taronna R. Maines, Hannah M. Creager, Gregory M. Glenn, Peter Pushko, Gale Smith, Terrence M. Tumpey	2015	54
14	Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice Vaccine ·Christopher M. Coleman, Ye V. Liu, Haiyan Mu, Justin Taylor, Michael J. Massare, David C. Flyer, Gregory M. Glenn, Gale Smith, Matthew B. Frieman	2014	226
15	An insect cell derived respiratory syncytial virus (RSV) F nanoparticle vaccine induces antigenic site II antibodies and protects against RSV challenge in cotton rats by active and passive immunization Vaccine ·Rama Raghunandan, Hanxin Lu, Bin Zhou, Mimi Guebre Xabier, Michael J. Massare, David C. Flyer, Louis Fries, Gale Smith, Gregory M. Glenn	2014	56
16	Respiratory Syncytial Virus Fusion Glycoprotein Expressed in Insect Cells Form Protein Nanoparticles That Induce Protective Immunity in Cotton Rats PLoS ONE ·Gale Smith, Rama Raghunandan, Yingyun Wu, Ye Liu, Michael J. Massare, Margret Nathan, Bin Zhou, Hanxin Lu, Sarathi Boddapati, Jingning Li, David C. Flyer, Gregory M. Glenn	2012	124
17	Assembly and Immunological Properties of Newcastle Disease Virus-Like Particles Containing the Respiratory Syncytial Virus F and G Proteins Journal of Virology ·Lori W. McGinnes, Kathryn A. Gravel, Robert W. Finberg, Evelyn A. Kurt‐Jones, Michael J. Massare, Gale Smith, Madelyn R. Schmidt, Trudy G. Morrison	2010	86
18	Newcastle Disease Virus-Like Particles Containing Respiratory Syncytial Virus G Protein Induced Protection in BALB/c Mice, with No Evidence of Immunopathology Journal of Virology ·Matthew R. Murawski, Lori W. McGinnes, Robert W. Finberg, Evelyn A. Kurt‐Jones, Michael J. Massare, Gale Smith, Penny M. Heaton, Armando E. Fraire, Trudy G. Morrison	2009	112
19	Inhibition of herpesvirus‐induced thymidine kinase and DNA polymerase by β‐hydroxynorvaline FEBS Letters ·Michael J. Massare, Herbert A. Blough	1987	2

About Michael J. Massare

Michael J. Massare is a scholar working on Infectious Diseases, Epidemiology, Modeling and Simulation, Agronomy and Crop Science and Animal Science and Zoology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Respiratory viral infections research (11 papers), Influenza Virus Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Viral gastroenteritis research and epidemiology (4 papers), Virology and Viral Diseases (3 papers), Neonatal Respiratory Health Research (3 papers), Animal Disease Management and Epidemiology (2 papers) and Animal Virus Infections Studies (2 papers). The work is most often cited by research in Infectious Diseases (869 citations), Animal Science and Zoology (202 citations), Epidemiology (554 citations), Immunology (234 citations) and Health (68 citations). Michael J. Massare has collaborated with scholars based in United States. Frequent co-authors include Gale Smith, Gregory M. Glenn, David C. Flyer, Bin Zhou, Matthew B. Frieman, Nita Patel, Ye V. Liu, Jing-Hui Tian, Alyse D. Portnoff and Justin Taylor. Their work appears in journals such as Vaccine, Vaccines, Journal of Virology, PLoS ONE and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact